Nova Capital Backs Shakespeare Monofilament Acquisition With £5.92m Funding Package

Nova Capital Backs Shakespeare Monofilament Acquisition With £5.92m Funding Package

Nova Capital Management has completed the acquisition of Shakespeare Monofilament UK with support from a £5.92 million asset-based lending facility. The funding package provides Shakespeare with additional working capital and longer-term financing as the business moves into its next phase under Nova’s ownership. It includes a £2.5 million confidential invoice discounting facility, a £1.5 million inventory revolver, £222,000 secured against plant…